The global H1N1 Vaccines market was valued at US$ 4316.4 million in 2023 and is projected to reach US$ 5453 million by 2030, at a CAGR of 3.4% during the forecast period.
The USA market for Global H1N1 Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global H1N1 Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global H1N1 Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the H1N1 Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global H1N1 Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of H1N1 Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global H1N1 Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The H1N1 Vaccines market presents opportunities for various stakeholders, including Influenza, Meningococcal. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in H1N1 Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
Key Features:
The research report on the H1N1 Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the H1N1 Vaccines market.
Market Overview: The report provides a comprehensive overview of the H1N1 Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Intramuscular Vaccines, Intranasal Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the H1N1 Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the H1N1 Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the H1N1 Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the H1N1 Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the H1N1 Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the H1N1 Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for H1N1 Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the H1N1 Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
H1N1 Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Intramuscular Vaccines
- Intranasal Vaccines
- Intradermal Vaccines
Market segment by Application
- Influenza
- Meningococcal
- Cervical Cancer
- Pneumococcal
- Hepatitis
- Measles
- Mumps
- Rubella
- Others
Global H1N1 Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Abbott
- Baxter International
- Sanofi
- GSK
- Pfizer
- Mitsubishi Tanabe Pharma
- Hualan Biological Engineering
- Cipla
- Merck
- Sinovac Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of H1N1 Vaccines, market overview.
Chapter 2: Global H1N1 Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of H1N1 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global H1N1 Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 H1N1 Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global H1N1 Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global H1N1 Vaccines Overall Market Size
2.1 Global H1N1 Vaccines Market Size: 2023 VS 2030
2.2 Global H1N1 Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global H1N1 Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top H1N1 Vaccines Players in Global Market
3.2 Top Global H1N1 Vaccines Companies Ranked by Revenue
3.3 Global H1N1 Vaccines Revenue by Companies
3.4 Global H1N1 Vaccines Sales by Companies
3.5 Global H1N1 Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 H1N1 Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers H1N1 Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 H1N1 Vaccines Players in Global Market
3.8.1 List of Global Tier 1 H1N1 Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 H1N1 Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global H1N1 Vaccines Market Size Markets, 2023 & 2030
4.1.2 Intramuscular Vaccines
4.1.3 Intranasal Vaccines
4.1.4 Intradermal Vaccines
4.2 By Type - Global H1N1 Vaccines Revenue & Forecasts
4.2.1 By Type - Global H1N1 Vaccines Revenue, 2019-2024
4.2.2 By Type - Global H1N1 Vaccines Revenue, 2025-2030
4.2.3 By Type - Global H1N1 Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global H1N1 Vaccines Sales & Forecasts
4.3.1 By Type - Global H1N1 Vaccines Sales, 2019-2024
4.3.2 By Type - Global H1N1 Vaccines Sales, 2025-2030
4.3.3 By Type - Global H1N1 Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global H1N1 Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global H1N1 Vaccines Market Size, 2023 & 2030
5.1.2 Influenza
5.1.3 Meningococcal
5.1.4 Cervical Cancer
5.1.5 Pneumococcal
5.1.6 Hepatitis
5.1.7 Measles
5.1.8 Mumps
5.1.9 Rubella
5.1.10 Others
5.2 By Application - Global H1N1 Vaccines Revenue & Forecasts
5.2.1 By Application - Global H1N1 Vaccines Revenue, 2019-2024
5.2.2 By Application - Global H1N1 Vaccines Revenue, 2025-2030
5.2.3 By Application - Global H1N1 Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global H1N1 Vaccines Sales & Forecasts
5.3.1 By Application - Global H1N1 Vaccines Sales, 2019-2024
5.3.2 By Application - Global H1N1 Vaccines Sales, 2025-2030
5.3.3 By Application - Global H1N1 Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global H1N1 Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global H1N1 Vaccines Market Size, 2023 & 2030
6.2 By Region - Global H1N1 Vaccines Revenue & Forecasts
6.2.1 By Region - Global H1N1 Vaccines Revenue, 2019-2024
6.2.2 By Region - Global H1N1 Vaccines Revenue, 2025-2030
6.2.3 By Region - Global H1N1 Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global H1N1 Vaccines Sales & Forecasts
6.3.1 By Region - Global H1N1 Vaccines Sales, 2019-2024
6.3.2 By Region - Global H1N1 Vaccines Sales, 2025-2030
6.3.3 By Region - Global H1N1 Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America H1N1 Vaccines Revenue, 2019-2030
6.4.2 By Country - North America H1N1 Vaccines Sales, 2019-2030
6.4.3 US H1N1 Vaccines Market Size, 2019-2030
6.4.4 Canada H1N1 Vaccines Market Size, 2019-2030
6.4.5 Mexico H1N1 Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe H1N1 Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe H1N1 Vaccines Sales, 2019-2030
6.5.3 Germany H1N1 Vaccines Market Size, 2019-2030
6.5.4 France H1N1 Vaccines Market Size, 2019-2030
6.5.5 U.K. H1N1 Vaccines Market Size, 2019-2030
6.5.6 Italy H1N1 Vaccines Market Size, 2019-2030
6.5.7 Russia H1N1 Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries H1N1 Vaccines Market Size, 2019-2030
6.5.9 Benelux H1N1 Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia H1N1 Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia H1N1 Vaccines Sales, 2019-2030
6.6.3 China H1N1 Vaccines Market Size, 2019-2030
6.6.4 Japan H1N1 Vaccines Market Size, 2019-2030
6.6.5 South Korea H1N1 Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia H1N1 Vaccines Market Size, 2019-2030
6.6.7 India H1N1 Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America H1N1 Vaccines Revenue, 2019-2030
6.7.2 By Country - South America H1N1 Vaccines Sales, 2019-2030
6.7.3 Brazil H1N1 Vaccines Market Size, 2019-2030
6.7.4 Argentina H1N1 Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa H1N1 Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa H1N1 Vaccines Sales, 2019-2030
6.8.3 Turkey H1N1 Vaccines Market Size, 2019-2030
6.8.4 Israel H1N1 Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia H1N1 Vaccines Market Size, 2019-2030
6.8.6 UAE H1N1 Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott H1N1 Vaccines Major Product Offerings
7.1.4 Abbott H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 Baxter International
7.2.1 Baxter International Company Summary
7.2.2 Baxter International Business Overview
7.2.3 Baxter International H1N1 Vaccines Major Product Offerings
7.2.4 Baxter International H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Baxter International Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi H1N1 Vaccines Major Product Offerings
7.3.4 Sanofi H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Sanofi Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK H1N1 Vaccines Major Product Offerings
7.4.4 GSK H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 GSK Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer H1N1 Vaccines Major Product Offerings
7.5.4 Pfizer H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Pfizer Key News & Latest Developments
7.6 Mitsubishi Tanabe Pharma
7.6.1 Mitsubishi Tanabe Pharma Company Summary
7.6.2 Mitsubishi Tanabe Pharma Business Overview
7.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Major Product Offerings
7.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.7 Hualan Biological Engineering
7.7.1 Hualan Biological Engineering Company Summary
7.7.2 Hualan Biological Engineering Business Overview
7.7.3 Hualan Biological Engineering H1N1 Vaccines Major Product Offerings
7.7.4 Hualan Biological Engineering H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Hualan Biological Engineering Key News & Latest Developments
7.8 Cipla
7.8.1 Cipla Company Summary
7.8.2 Cipla Business Overview
7.8.3 Cipla H1N1 Vaccines Major Product Offerings
7.8.4 Cipla H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 Cipla Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck H1N1 Vaccines Major Product Offerings
7.9.4 Merck H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Merck Key News & Latest Developments
7.10 Sinovac Biotech
7.10.1 Sinovac Biotech Company Summary
7.10.2 Sinovac Biotech Business Overview
7.10.3 Sinovac Biotech H1N1 Vaccines Major Product Offerings
7.10.4 Sinovac Biotech H1N1 Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 Sinovac Biotech Key News & Latest Developments
8 Global H1N1 Vaccines Production Capacity, Analysis
8.1 Global H1N1 Vaccines Production Capacity, 2019-2030
8.2 H1N1 Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global H1N1 Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 H1N1 Vaccines Supply Chain Analysis
10.1 H1N1 Vaccines Industry Value Chain
10.2 H1N1 Vaccines Upstream Market
10.3 H1N1 Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 H1N1 Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of H1N1 Vaccines in Global Market
Table 2. Top H1N1 Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global H1N1 Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global H1N1 Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global H1N1 Vaccines Sales by Companies, (K Units), 2019-2024
Table 6. Global H1N1 Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers H1N1 Vaccines Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers H1N1 Vaccines Product Type
Table 9. List of Global Tier 1 H1N1 Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 H1N1 Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global H1N1 Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global H1N1 Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global H1N1 Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global H1N1 Vaccines Sales (K Units), 2019-2024
Table 15. By Type - Global H1N1 Vaccines Sales (K Units), 2025-2030
Table 16. By Application ? Global H1N1 Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global H1N1 Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global H1N1 Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global H1N1 Vaccines Sales (K Units), 2019-2024
Table 20. By Application - Global H1N1 Vaccines Sales (K Units), 2025-2030
Table 21. By Region ? Global H1N1 Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global H1N1 Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global H1N1 Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global H1N1 Vaccines Sales (K Units), 2019-2024
Table 25. By Region - Global H1N1 Vaccines Sales (K Units), 2025-2030
Table 26. By Country - North America H1N1 Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America H1N1 Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America H1N1 Vaccines Sales, (K Units), 2019-2024
Table 29. By Country - North America H1N1 Vaccines Sales, (K Units), 2025-2030
Table 30. By Country - Europe H1N1 Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe H1N1 Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe H1N1 Vaccines Sales, (K Units), 2019-2024
Table 33. By Country - Europe H1N1 Vaccines Sales, (K Units), 2025-2030
Table 34. By Region - Asia H1N1 Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia H1N1 Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia H1N1 Vaccines Sales, (K Units), 2019-2024
Table 37. By Region - Asia H1N1 Vaccines Sales, (K Units), 2025-2030
Table 38. By Country - South America H1N1 Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America H1N1 Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America H1N1 Vaccines Sales, (K Units), 2019-2024
Table 41. By Country - South America H1N1 Vaccines Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa H1N1 Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa H1N1 Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa H1N1 Vaccines Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa H1N1 Vaccines Sales, (K Units), 2025-2030
Table 46. Abbott Company Summary
Table 47. Abbott H1N1 Vaccines Product Offerings
Table 48. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Abbott Key News & Latest Developments
Table 50. Baxter International Company Summary
Table 51. Baxter International H1N1 Vaccines Product Offerings
Table 52. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Baxter International Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi H1N1 Vaccines Product Offerings
Table 56. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Sanofi Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK H1N1 Vaccines Product Offerings
Table 60. GSK H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. GSK Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer H1N1 Vaccines Product Offerings
Table 64. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Pfizer Key News & Latest Developments
Table 66. Mitsubishi Tanabe Pharma Company Summary
Table 67. Mitsubishi Tanabe Pharma H1N1 Vaccines Product Offerings
Table 68. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Mitsubishi Tanabe Pharma Key News & Latest Developments
Table 70. Hualan Biological Engineering Company Summary
Table 71. Hualan Biological Engineering H1N1 Vaccines Product Offerings
Table 72. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Hualan Biological Engineering Key News & Latest Developments
Table 74. Cipla Company Summary
Table 75. Cipla H1N1 Vaccines Product Offerings
Table 76. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Cipla Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck H1N1 Vaccines Product Offerings
Table 80. Merck H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Merck Key News & Latest Developments
Table 82. Sinovac Biotech Company Summary
Table 83. Sinovac Biotech H1N1 Vaccines Product Offerings
Table 84. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Sinovac Biotech Key News & Latest Developments
Table 86. H1N1 Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global H1N1 Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global H1N1 Vaccines Production by Region, 2019-2024 (K Units)
Table 89. Global H1N1 Vaccines Production by Region, 2025-2030 (K Units)
Table 90. H1N1 Vaccines Market Opportunities & Trends in Global Market
Table 91. H1N1 Vaccines Market Drivers in Global Market
Table 92. H1N1 Vaccines Market Restraints in Global Market
Table 93. H1N1 Vaccines Raw Materials
Table 94. H1N1 Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical H1N1 Vaccines Downstream
Table 96. H1N1 Vaccines Downstream Clients in Global Market
Table 97. H1N1 Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. H1N1 Vaccines Segment by Type in 2023
Figure 2. H1N1 Vaccines Segment by Application in 2023
Figure 3. Global H1N1 Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global H1N1 Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global H1N1 Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. H1N1 Vaccines Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by H1N1 Vaccines Revenue in 2023
Figure 9. By Type - Global H1N1 Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global H1N1 Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global H1N1 Vaccines Price (USD/Unit), 2019-2030
Figure 13. By Application - Global H1N1 Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global H1N1 Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global H1N1 Vaccines Price (USD/Unit), 2019-2030
Figure 17. By Region - Global H1N1 Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global H1N1 Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global H1N1 Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America H1N1 Vaccines Sales Market Share, 2019-2030
Figure 23. US H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe H1N1 Vaccines Sales Market Share, 2019-2030
Figure 28. Germany H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia H1N1 Vaccines Sales Market Share, 2019-2030
Figure 37. China H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America H1N1 Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa H1N1 Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa H1N1 Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE H1N1 Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global H1N1 Vaccines Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production H1N1 Vaccines by Region, 2023 VS 2030
Figure 54. H1N1 Vaccines Industry Value Chain
Figure 55. Marketing Channels
